{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:04:58Z","timestamp":1790888698283,"version":"4.1.0"},"reference-count":37,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2022,11,15]]},"abstract":"<jats:p>\n            We evaluated the\n            <jats:italic>in vitro<\/jats:italic>\n            activity of manogepix and comparator agents against 1,435 contemporary fungal isolates collected worldwide from 73 medical centers in North America, Europe, the Asia-Pacific region, and Latin America during 2020. Of the isolates tested, 74.7% were\n            <jats:italic>Candida<\/jats:italic>\n            spp.; 3.7% were non-\n            <jats:italic>Candida<\/jats:italic>\n            yeasts, including 27\n            <jats:named-content content-type=\"genus-species\">Cryptococcus neoformans<\/jats:named-content>\n            var.\n            <jats:italic>grubii<\/jats:italic>\n            (1.9%); 17.1% were\n            <jats:named-content content-type=\"genus-species\">Aspergillus<\/jats:named-content>\n            spp.; and 4.5% were other molds.\n          <\/jats:p>","DOI":"10.1128\/aac.01028-22","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T13:00:22Z","timestamp":1666789222000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":31,"title":["Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020)"],"prefix":"10.1128","volume":"66","author":[{"given":"M. A.","family":"Pfaller","sequence":"first","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa, USA"},{"name":"University of Iowa, Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9769-9019","authenticated-orcid":true,"given":"M. D.","family":"Huband","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. R.","family":"Rhomberg","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Bien","sequence":"additional","affiliation":[{"name":"Pfizer Inc., New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-1782","authenticated-orcid":true,"given":"M.","family":"Castanheira","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00214"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040057"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof6030138"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-015-2374-1"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof5030067"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.aambs.2019.10.003"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.28327.1"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00730-20"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.732223"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa016"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-021-00419-5"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.04.012"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040239"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00731-11"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00485-17"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00429-20"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00656-20"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05414-11"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00366-11"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00840-19"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz022"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03944-14"},{"key":"e_1_3_3_24_2","unstructured":"Clinical and Laboratory Standards Institute. 2022. Performance standards for antifungal susceptibility testing of yeasts. CLSI M27M44S. Clinical and Laboratory Standards Institute Wayne PA. https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m27m44s\/."},{"key":"e_1_3_3_25_2","volume-title":"Principles and procedures for the development of epidemiological cutoff values for antifungal susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2016","unstructured":"Clinical and Laboratory Standards Institute. 2016. Principles and procedures for the development of epidemiological cutoff values for antifungal susceptibility testing, 1st ed. CLSI M57S. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"1"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01564-17"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof4040129"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00261-20"},{"key":"e_1_3_3_29_2","first-page":"219","volume-title":"Methods in microbiology","author":"Pfaller MA","year":"2015","unstructured":"Pfaller MA. 2015. Invasive fungal infections and approaches to their diagnosis, p 219\u2013287. In Sails A, Tang Y (ed), Methods in microbiology, vol 72. Academic Pres, Oxford, United Kingdom."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-012-9551-x"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01230-18"},{"key":"e_1_3_3_32_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"Clinical and Laboratory Standards Institute","year":"2017","unstructured":"Clinical and Laboratory Standards Institute. 2017. Reference method for broth dilution antifungal susceptibility testing of yeasts. CLSI M27Ed4. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_3_33_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, 3rd ed. CLSI M38Ed3. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"3"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr342"},{"key":"e_1_3_3_35_2","unstructured":"Clinical and Laboratory Standards Institute. 2022. Performance standards for antifungal susceptibility testing of filamentous fungi. CLSI M38M51S. Clinical and Laboratory Standards Institute Wayne PA. https:\/\/clsi.org\/media\/retijtfi\/m38m51sed3e_sample.pdf."},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00906-17"},{"key":"e_1_3_3_37_2","unstructured":"Joshi N Fass JN. 2011. Sickle: a sliding-window adaptive quality-based trimming tool for FastQ files version 1.33. https:\/\/github.com\/najoshi\/sickle. Accessed 30 September 2019."},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1089\/cmb.2013.0084"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01028-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01028-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T13:01:00Z","timestamp":1668517260000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01028-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,15]]}},"alternative-id":["10.1128\/aac.01028-22"],"URL":"https:\/\/doi.org\/10.1128\/aac.01028-22","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"2022-07-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01028-22"}}